HIGHLIGHTS
- who: Qianqian Zhang and Suhui Wu from the Yale University, United States have published the paper: Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response, in the Journal: (JOURNAL)
- what: By leveraging this information, the authors describe how TLSs can be used to predict clinical outcomes and immunotherapeutic responses and manipulate anticancer immune_responses in a targeted manner.
- future: A detailed analysis of the expression of immune checkpoint molecules in tumor-infiltrating immunoregulatory cells and the study of individual TLSs during tumor progression are important future directions. Future work comparing the TLS . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.